{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:35:36Z","timestamp":1787808936783,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1245\/s10434-021-10750-3","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:14:53Z","timestamp":1630718093000},"page":"924-932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality"],"prefix":"10.1245","volume":"29","author":[{"given":"Kazumasa","family":"Fujitani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Osaka University Clinical Research Group for Gastroenterological Surgery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"10750_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"10750_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/bjs.1800810832","volume":"81","author":"T Ochiai","year":"1994","unstructured":"Ochiai T, Sasako M, Mizuno S, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg. 1994;81:1175\u20138.","journal-title":"Br J Surg."},{"key":"10750_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0002-9610(01)00567-0","volume":"181","author":"S Ambiru","year":"2001","unstructured":"Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001;181:279\u201383.","journal-title":"Am J Surg."},{"key":"10750_CR4","first-page":"1062","volume":"49","author":"A Saiura","year":"2002","unstructured":"Saiura A, Umekita N, Inoue S, et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology. 2002;49:1062\u20135.","journal-title":"Hepatogastroenterology."},{"key":"10750_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00000658-200201000-00011","volume":"235","author":"K Okano","year":"2002","unstructured":"Okano K, Maeba T, Ishimura K, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002;235:86\u201391.","journal-title":"Ann Surg."},{"key":"10750_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1091-255X(01)00075-0","volume":"6","author":"J Zacherl","year":"2002","unstructured":"Zacherl J, Zacherl M, Scheuba C, et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg. 2002;6:682\u20139.","journal-title":"J Gastrointest Surg."},{"key":"10750_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1067\/msy.2003.147","volume":"133","author":"Y Sakamoto","year":"2003","unstructured":"Sakamoto Y, Ohyama S, Yamamoto J, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003;133:507\u201311.","journal-title":"Surgery."},{"key":"10750_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jso.20739","volume":"95","author":"Y Sakamoto","year":"2007","unstructured":"Sakamoto Y, Sano T, Shimada K, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol. 2007;95:534\u20139.","journal-title":"J Surg Oncol."},{"key":"10750_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/annonc\/mdn026","volume":"19","author":"SH Cheon","year":"2008","unstructured":"Cheon SH, Rha SY, Jeung HC, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol. 2008;19:1146\u201353.","journal-title":"Ann Oncol."},{"key":"10750_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa073149","volume":"358","author":"D Cunningham","year":"2008","unstructured":"Cunningham D, Starling N, Rao S, et al. Upper Gastrointestinal clinical studies group of the national cancer research institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358:36\u201346.","journal-title":"N Engl J Med."},{"key":"10750_CR11","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/annonc\/mdn403","volume":"19","author":"SE Al-Batran","year":"2008","unstructured":"Al-Batran SE, Hartmann JT, Hofheinz R, et al. Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol. 2008;19:1882\u20137.","journal-title":"Ann Oncol."},{"key":"10750_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","volume":"26","author":"SE Al-Batran","year":"2008","unstructured":"Al-Batran SE, Hartmann JT, Probst S, et al. Arbeitsgemeinschaft Internistische Onkologie. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol. 2008;26:1435\u201342.","journal-title":"J Clin Oncol."},{"key":"10750_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321.","journal-title":"Lancet Oncol."},{"key":"10750_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1470-2045(09)70259-1","volume":"10","author":"N Boku","year":"2009","unstructured":"Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10:1063\u20139.","journal-title":"Lancet Oncol."},{"key":"10750_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, et al. ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687\u201397.","journal-title":"Lancet."},{"key":"10750_CR16","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1200\/JCO.2013.54.1011","volume":"32","author":"R Guimbaud","year":"2014","unstructured":"Guimbaud R, Louvet C, Ries P, et al. Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Federation Francophone de Cancerologie Digestive, Federation Nationale des Centres de Lutte Contre le Cancer, and Groupe Cooperateur Multidisciplinaire en Oncologie) study. J Clin Oncol. 2014;32:3520\u20136.","journal-title":"J Clin Oncol."},{"key":"10750_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/annonc\/mdu472","volume":"26","author":"Y Yamada","year":"2015","unstructured":"Yamada Y, Higuchi K, Nishikawa K, et al. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer. Ann Oncol. 2015;26:141\u20138.","journal-title":"Ann Oncol."},{"key":"10750_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S2468-1253(19)30083-4","volume":"4","author":"Y Yamada","year":"2019","unstructured":"Yamada Y, Boku N, Mizusawa J, et al. Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4:501\u201310.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10750_CR19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.sla.0000246847.02058.1b","volume":"244","author":"R Adam","year":"2006","unstructured":"Adam R, Chiche L, Aloia T, et al. Association Fran\u00e7aise de Chirurgie. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model. Ann Surg. 2006;244:524\u201335.","journal-title":"Ann Surg."},{"key":"10750_CR20","first-page":"665","volume":"32","author":"Y Miki","year":"2012","unstructured":"Miki Y, Fujitani K, Hirao M, et al. Significance of surgical treatment of liver metastases from gastric cancer. Anticancer Res. 2012;32:665\u201370.","journal-title":"Anticancer Res."},{"key":"10750_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00423-012-0959-z","volume":"397","author":"N Takemura","year":"2012","unstructured":"Takemura N, Saiura A, Koga R, et al. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg. 2012;397:951\u20137.","journal-title":"Langenbecks Arch Surg."},{"key":"10750_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s10120-013-0299-x","volume":"17","author":"Y Kodera","year":"2014","unstructured":"Kodera Y, Fujitani K, Fukushima N, et al. Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines. Gastric Cancer. 2014;17:206\u201312.","journal-title":"Gastric Cancer."},{"key":"10750_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/bjs.9684","volume":"102","author":"T Kinoshita","year":"2015","unstructured":"Kinoshita T, Kinoshita T, Saiura A, Esaki M, Sakamoto H, Yamanaka T. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg. 2015;102:102\u20137.","journal-title":"Br J Surg."},{"key":"10750_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/SLA.0000000000001542","volume":"263","author":"SR Markar","year":"2016","unstructured":"Markar SR, Mikhail S, Malietzis G, et al. Influence of surgical resection of hepatic metastases from gastric adenocarcinoma on long-term survival: systematic review and pooled analysis. Ann Surg. 2016;263:1092\u2013101.","journal-title":"Ann Surg."},{"key":"10750_CR25","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s10120-015-0530-z","volume":"19","author":"E Oki","year":"2016","unstructured":"Oki E, Tokunaga S, Emi Y, et al. Kyushu Study Group of Clinical Cancer. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer. 2016;19:968\u201376.","journal-title":"Gastric Cancer."},{"key":"10750_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10120-016-0604-6","volume":"20","author":"SR Markar","year":"2017","unstructured":"Markar SR, Mackenzie H, Mikhail S, et al. Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England. Gastric Cancer. 2017;20:379\u201386.","journal-title":"Gastric Cancer."},{"key":"10750_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10120-017-0730-9","volume":"21","author":"H Shirasu","year":"2018","unstructured":"Shirasu H, Tsushima T, Kawahira M, et al. Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric Cancer. 2018;21:338\u201344.","journal-title":"Gastric Cancer."},{"key":"10750_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.5306\/wjco.v11.i7.477","volume":"11","author":"F Uggeri","year":"2020","unstructured":"Uggeri F, Ripamonti L, Pinotti E, et al. Is there a role for treatment-oriented surgery in liver metastases from gastric cancer? World J Clin Oncol. 2020;11:477\u201394.","journal-title":"World J Clin Oncol."},{"key":"10750_CR29","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/bjc.2014.18","volume":"110","author":"Y Kurokawa","year":"2014","unstructured":"Kurokawa Y, Sugimoto N, Miwa H, et al. Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1). Br J Cancer. 2014;110:1163\u20138.","journal-title":"Br J Cancer."},{"key":"10750_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ejca.2014.12.015","volume":"51","author":"MH Ryu","year":"2015","unstructured":"Ryu MH, Yoo C, Kim JG, et al. Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer. Eur J Cancer. 2015;51:482\u20138.","journal-title":"Eur J Cancer."},{"key":"10750_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ejca.2015.02.009","volume":"51","author":"K Nishikawa","year":"2015","unstructured":"Nishikawa K, Fujitani K, Inagaki H, et al. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial. Eur J Cancer. 2015;51:808\u201316.","journal-title":"Eur J Cancer."},{"key":"10750_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/PL00011681","volume":"1","author":"Japanese Gastric Cancer Association","year":"1998","unstructured":"Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English edition. Gastric Cancer. 1998;1:8\u201324.","journal-title":"Gastric Cancer"},{"key":"10750_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646\u20139.","journal-title":"Br J Surg."},{"key":"10750_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/hepr.12464","volume":"45","author":"N Kokudo","year":"2015","unstructured":"Kokudo N, Hasegawa K, Akahane M, et al. Evidence-based clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res. 2015;45:123\u20137.","journal-title":"Hepatol Res."},{"key":"10750_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10120-011-0042-4","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113\u201323.","journal-title":"Gastric Cancer."},{"key":"10750_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg."},{"key":"10750_CR37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","volume":"240","author":"M D'Angelica","year":"2004","unstructured":"D\u2019Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808\u201316.","journal-title":"Ann Surg."},{"key":"10750_CR38","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3389\/fonc.2019.01353","volume":"9","author":"Z Luo","year":"2019","unstructured":"Luo Z, Rong Z, Huang C. Surgery strategies for gastric cancer with liver metastasis. Front Oncol. 2019;9:1353.","journal-title":"Front Oncol."},{"key":"10750_CR39","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1\u201321.","DOI":"10.1007\/s10120-020-01042-y"},{"key":"10750_CR40","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/jjco\/hyh120","volume":"34","author":"M Yoshida","year":"2004","unstructured":"Yoshida M, Ohtsu A, Boku N, et al. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol. 2004;34:654\u20139.","journal-title":"Jpn J Clin Oncol."},{"key":"10750_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s10120-017-0696-7","volume":"20","author":"K Kataoka","year":"2017","unstructured":"Kataoka K, Kinoshita T, Moehler M, et al. On behalf of EORTC GITCG Group and JCOG SCGC Group, Current management of liver metastases from gastric cancer: What is common practice? New challenge of EORTC and JCOG. Gastric Cancer. 2017;20:904\u201312.","journal-title":"Gastric Cancer"},{"key":"10750_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10120-016-0611-7","volume":"20","author":"T Tatsubayashi","year":"2017","unstructured":"Tatsubayashi T, Tanizawa Y, Miki Y, et al. Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer. 2017;20:387\u201393.","journal-title":"Gastric Cancer."},{"key":"10750_CR43","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/01.sla.0000145964.08365.01","volume":"240","author":"R Adam","year":"2004","unstructured":"Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240:1052\u201361.","journal-title":"Ann Surg."},{"key":"10750_CR44","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","volume":"16","author":"G Folprecht","year":"2005","unstructured":"Folprecht G, Grothey A, Alberts S, Raab HR, K\u00f6hne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005;16:1311\u20139.","journal-title":"Ann Oncol."},{"key":"10750_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000505555","volume":"98","author":"T Arigami","year":"2020","unstructured":"Arigami T, Matsushita D, Okubo K, et al. Indication and prognostic significance of conversion surgery in patients with liver metastasis from gastric cancer. Oncology. 2020;98:273\u20139.","journal-title":"Oncology."},{"key":"10750_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.bjc.6603670","volume":"96","author":"FKS Welsh","year":"2007","unstructured":"Welsh FKS, Tilney HS, Tekkis PP, John TG, Rees M. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer. 2007;96:1037\u201342.","journal-title":"Br J Cancer."},{"key":"10750_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","volume":"243","author":"M Karoui","year":"2006","unstructured":"Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1\u20137.","journal-title":"Ann Surg."},{"key":"10750_CR48","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bjs.9484","volume":"101","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M, Stomach Cancer Study Group of the Japan Clinical Oncology Group. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653\u201360.","journal-title":"Br J Surg."},{"key":"10750_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309\u201318.","journal-title":"Ann Surg."},{"key":"10750_CR50","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1046\/j.0007-1323.2001.01821.x","volume":"88","author":"J Figueras","year":"2001","unstructured":"Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg. 2001;88:980\u20135.","journal-title":"Br J Surg."},{"key":"10750_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","volume":"240","author":"R Adam","year":"2004","unstructured":"Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644\u201357.","journal-title":"Ann Surg."},{"key":"10750_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","volume":"247","author":"M Rees","year":"2008","unstructured":"Rees M, Tekkis PP, Welsh FKS, O\u2019Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125\u201335.","journal-title":"Ann Surg."},{"key":"10750_CR53","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","volume":"3","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3:1237\u201344.","journal-title":"JAMA Oncol."},{"key":"10750_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","volume":"17","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Goetze TO, Mueller DW, et al. RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction\u2014a phase III trial of the German AIO\/CAO-V\/CAOGI. BMC Cancer. 2017;17:893.","journal-title":"BMC Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10750-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10750-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10750-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T04:32:34Z","timestamp":1675657954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10750-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10750"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10750-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"28 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}